Evaluation of Dose-response, Pharmacodynamic and Pharmacokinetic Bioequivalence of Filgrastim in Healthy Male Volunteers After Single and Multiple-dose Subcutaneous Administration of the Test Injectable Formulation BK0023 vs. Neupogen®
Clinical trial NCT01933971 · COMPLETED
Trial details
- NCT number
- NCT01933971
- Sponsor
- Bio-ker S.r.l.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-04-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.